Treatment of diabetes with glucagon-like peptide-1 gene therapy

By Riedel Michael J   Kieffer Timothy J  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 12, 2010-12 ,pp. : 1681-1692

Informa Healthcare

Access to resources Recommend Favorite

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds

By Yasuda N.   Inoue T.   Nagakura T.   Yamazaki K.   Kira K.   Saeki T.   Tanaka I.  

Biochemical and Biophysical Research Communications, Vol. 298, Iss. 5, 2002-11 ,pp. : 779-784

Elsevier

Access to resources Recommend Favorite

Metformin Effects on Dipeptidylpeptidase IV Degradation of Glucagon-like Peptide-1

By Hinke S.A.   Kühn-Wache K.   Hoffmann T.   Pederson R.A.   McIntosh C.H.S.   Demuth H-U.  

Biochemical and Biophysical Research Communications, Vol. 291, Iss. 5, 2002-03 ,pp. : 1302-1308

Elsevier

Access to resources Recommend Favorite

Bioactive Compounds Extracted from Ecklonia cava by Using Enzymatic Hydrolysis Protects High Glucose-Induced Damage in INS-1 Pancreatic β-Cells

By Lee Seung-Hong  

Applied Biochemistry and Biotechnology, Vol. 167, Iss. 7, 2012-08 ,pp. : 1973-1985

Humana Press, Inc

Access to resources Recommend Favorite

Point Mutations in the First and Third Intracellular Loops of the Glucagon-like Peptide-1 Receptor Alter Intracellular Signaling

By Heller R.S.   Kieffer T.J.   Habener J.F.  

Biochemical and Biophysical Research Communications, Vol. 223, Iss. 3, 1996-06 ,pp. : 624-632

Elsevier

Access to resources Recommend Favorite